Texting to Reduce Human Immunodeficiency Virus (HIV) Risk

Recruiting N/A Interventional Study
HIV Infections
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
266 (estimated)
Sponsor
Boston University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is a 3-year study to test the efficacy of a text message-based intervention program. Dental patients at 4 community health centers (n= 266) will be randomized to receive either text messages (TMs) regarding HIV prevention or TMs regarding overall wellness. Prior to enrolling the 266 participants, the investigators will conduct a feasibility pilot (n=20) to test the TM delivery as well as all …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Give informed consent and document consent via a signed and dated informed consent form in REDCap * Willing to comply with all study procedures and be available for the duration of the study * Be able to read either in English or Spanish * Be a dental clinic patient of record …
Contacts

Michelle Henshaw, DDS, MPH

:617-358-6111

mhenshaw@bu.edu

CONTACT

Gabriel Federo Hungria, MD, MSCR

617-358-6490

gfedero@bu.edu

CONTACT